Metraipolis › archive › dc_08b3f494ec32

Preclinical efficacy of combination therapy with allogeneic induced pluripotent stem cell-derived invariant natural killer T and α-galactosylceramide-pulsed… — Europe PMC PMID:41904478

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41904478
DOI
10.1186/s13287-[numero omesso]-7
License (as archived)
solo-consultazione
Archived
2026-11-03T17:34:52.718Z
SHA-256 of the archived text
b2eb7aca2f24d07a54b79cf7c4654dd93ffbc9e206b4eae4e2500f922679a7df
Stable URL of this page
https://metraipolis.com/documento/dc_08b3f494ec32

How to cite

Preclinical efficacy of combination therapy with allogeneic induced pluripotent stem cell-derived invariant natural killer T and α-galactosylceramide-pulsed… — Europe PMC PMID:41904478 — Europe PMC (en), https://europepmc.org/article/MED/41904478 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_08b3f494ec32 (Metraipolis archive dc_08b3f494ec32, sha256 b2eb7aca2f24d07a54b79cf7c4654dd93ffbc9e206b4eae4e2500f922679a7df)
BibTeX
@misc{dc08b3f494ec32,
  title = {Preclinical efficacy of combination therapy with allogeneic induced pluripotent stem cell-derived invariant natural killer T and α-galactosylceramide-pulsed… — Europe PMC PMID:41904478},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41904478},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_08b3f494ec32; sha256 b2eb7aca2f24d07a54b79cf7c4654dd93ffbc9e206b4eae4e2500f922679a7df},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41904478. Agents can read the archived copy with the MCP tool read_document.